Cardiometabolic Online Series (Multiple Modules)

The latest evidence-based data addressing cardiometabolic diseases is presented in this online series.


Lipid Management Program

The Lipid Management Program at Miami Cardiac & Vascular Institute is a resource to help patients who require additional expertise to assess their cardiovascular risk and to manage their lipids. Typically, primary care physicians, endocrinologists and cardiologists assess and monitor lipids in patients. Our Lipid Management Program is designed to help patients that are unable to tolerate traditional lipid management therapies or that have complex disorders that require specialized care. We work collaboratively with your physician to help you reach your lipid goal in a safe and well-tolerated way.

The Lipid Management Program is covered under insurance. Referrals from physicians are recommended but not required. Patients who are interested in the program are invited to call 786-204-4499 for more information or to set up a consultation with a cardiovascular lipid specialist.

Target Audience

Baptist Health Medical Group Physicians, Baptist Health Quality Network Physicians, Primary Care Physicians, Internal Medicine Physicians, Cardiologists, Interventional Cardiologists, Family Practitioners,  Endocrinologists, Obstetricians, Gynecologists, Physician Assistants, Dietitians, Nurses, Advanced Practice Registered Nurses, Pharmacists and all other healthcare professionals who care for patients with cardiometabolic diseases.

Course summary
Course opens: 
Course expires: 
imageTheodore Feldman, M.D., FACC, FACP
Medical Director, Center for Healthcare Advancement & Outcomes
Baptist Health South Florida
Medical Director, Prevention and Community Health
Miami Cardiac & Vascular Institute
Head of Cardiology & Clinical Associate Professor of Medicine
FIU Wertheim College of Medicine

Theodore Feldman, M.D., has indicated that he is on the speakers bureau for Novartis, Regeneron, Sanofi, Amgen, Boehringer Ingelheim and Novo Nordisk and is a consultant for Merck.
Jonathan Fialkow, M.D., FACC, FAHA

Cardiovascular Disease, Clinical Lipidologist
Deputy Medical Director
Chief of Cardiology
Miami Cardiac & Vascular Institute
Chief Population Health Officer
Baptist Health South Florida

Jonathan Fialkow, M.D., FACC, FAHA, has indicated that he is on the speakers bureau for Amgen and Amarin.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose. 

Disclosure Policy and Disclaimer.

See individual course pages for applicable credits and accreditations. 

Please login or register to take this course.